Skip to main content

[vc_row][vc_column][vc_column_text]FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng and Project Advances New Systems Biology Paradigm for Cancer Treatment World-First Phase...

[vc_row][vc_column][vc_column_text] Researchers at the University of Cardiff discovered that MR1-restricted T-cells can be used to broaden both the types of cancer and patients that can be treated using cellular therapy. During the past decade, cancer immunotherapy has emerged, along with surgery, radiation, and chemotherapy, as a fourth,...

[vc_row][vc_column][vc_single_image image="31110" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Scientists at the University of East Anglia and the Norfolk and Norwich University Hospital in the United Kingdom have developed a prostate cancer screening test that uses urine and can be completed at home. This new method, called the PUR...